# Finn Murphy

> Finn Murphy is a seed investor at Evervault (Dublin) backing Software, B2B and Medical. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Evervault](https://shizune.co/investors/profile/evervault)
- Location: Dublin, Ireland
- Total investments: 6
- Last investment: Dec 2024
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/finn-murphy-16160465/

Finn Murphy is a seed investor at Evervault in Dublin focused on Software and B2B. Finn just graduated from Mechanical Engineering in Trinity College finishing his 4th year exams with the highest grade in his class. His world view stems from his interest in engineering. Where there are problems he likes to find solutions, whether those problems are getting locked out of your house, not having clean drinking water or forgettingyour student card at home. Before settling on software development Finn dabbled in Ocean Sailing, Coaching, Event Management, Politics and Sports Management and Social Media.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $3.5M–$5.6M |
| Series A | $2.5M–$14M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 3 | 50% |
| B2B | 1 | 17% |
| Medical | 1 | 17% |
| Oncology | 1 | 17% |
| Recruiting | 1 | 17% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 50% |
| Series A | 2 | 33% |
| Pre-Seed | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Ireland | 2 | 33% |
| United Kingdom | 2 | 33% |
| Norway | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Luminate | Luminate is an oncology-focused healthtech and tech-enabled services company that partners with payers, providers, and people with cancer to reduce the cost of cancer care while improving quality of life and outcomes for patients. The company offers a portfolio of services and technologies that enable home-based cancer treatment, adverse eventmonitoring, and prevention of drug-induced side effects. | $2.5M | Series A | Dec 04, 2024 |  |
| Teton | The future of contactless patient monitoring to prevent exacerbation | $5.6M | Seed | Apr 05, 2023 |  |
| Omnea | Omnea offers a procurement orchestration platform that streamlines source-to-pay workflows. It enables organizations to centralize supplier data, renewals, approvals, and purchase order automation, while embedding risk management and sourcing tools. Omnea provides modules for intelligent intake (request management), a supplier portal for duediligence, and no-code workflow building to define processes and approvals. Omnea’s reporting suite delivers visibility into spend, supplier performance, and compliance, and AI features assist with RFx generation, policy-aligned document parsing, and risk assessments. The platform integrates with finance and legal systems to reduce manual effort, maintain governance, and ensure consistent supplier evaluation. | $5M | Seed | Jun 16, 2022 |  |
| Unleash | Unleash is an enterprise-ready open source feature management platform allowing developers and enterprises to have control over their product features and subsequent roll-out. | $14M | Series A | Mar 24, 2022 |  |
| Overwatch Research | Overwatch Research provides an all-in-one experimental tracking software for Vivo research. Overwatch Research affords to Save time, reduce error and increase collaboration in the lab. | $3.5M | Seed | Oct 19, 2021 |  |
| Swyg | Swyg is on a mission to eliminate bias from recruitment and to make interviewing fair for all. The Swyg platform helps companies make better hiring decisions by making the face-to-face interviewing process available for all candidates. Through our platform, candidates interview each other while an AI moderates and corrects for bias. Swyg creates abetter candidate experience by giving feedback to every candidate and makes companies more competitive in the search for talent by giving them deep insight into their candidate pool. | $1.2M | Pre-Seed | Sep 09, 2020 |  |

6 of 6 investments shown.

## Co-investors
- [Faber](https://shizune.co/investors/profile/faber-ventures) — VC Fund, 2 deals together
- [Alliance VC](https://shizune.co/investors/profile/alliance-venture) — VC Fund, 1 deal together
- [Arkwright X](https://shizune.co/investors/profile/arkwright-x) — VC Fund, 1 deal together
- [Atlantic Bridge](https://shizune.co/investors/profile/atlantic-bridge) — VC Fund, 1 deal together
- [Elkstone Capital Partners](https://shizune.co/investors/profile/elkstone-capital-partners) — VC Fund, 1 deal together
- [Entrepreneurs First](https://shizune.co/investors/profile/entrepreneurs-first) — VC Fund, 1 deal together

## About Evervault

VC Fund · Dublin, Ireland

Encryption infrastructure for developers.

3 contacts available at Evervault.

| Name | Title | Profile |
| --- | --- | --- |
| Shane Curran | CEO & Founder | https://shizune.co/investors/profile/shane-curran |
| Finn Murphy | Investor | https://shizune.co/investors/profile/finn-murphy |
| Stephanie Z. Colis | Investor, Seed and A | https://shizune.co/investors/profile/stephanie-zhan |

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund
- [NDRC](https://shizune.co/investors/profile/ndrc) — VC Fund
- [Act Venture Capital](https://shizune.co/investors/profile/act-venture-capital) — VC Fund

## Featured in investor lists
- [Health Care Angel Investors in Ireland](https://shizune.co/investors/health-care-angel-investors-ireland)
- [Medical Angel Investors in Ireland](https://shizune.co/investors/medical-angel-investors-ireland)

## FAQ

### What does Finn Murphy invest in?

Finn Murphy invests primarily in Software, B2B and Medical startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Finn Murphy's check size?

Finn Murphy typically joins rounds of $3.5M–$5.6M at Seed and $2.5M–$14M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Finn Murphy participates in.

### When did Finn Murphy last invest?

The most recent investment recorded for Finn Murphy closed in Dec 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co